Literature DB >> 16611210

Data mining in spontaneous reports.

Andrew Bate1, I R Edwards.   

Abstract

The increasing size of spontaneous report data sets and the increasing capability for screening such data due to increases in computational power has led to a recent increase in interest and use of data mining on such data. While data mining plays an important role in the analysis of spontaneous reports, there is general debate on how and when data mining should be best performed. While the cornerstone principles for data mining of spontaneous reports have been in place since the 1960s, several significant changes have occurred to make their use widespread. Superficially the Bayesian methods seem unnecessarily complex, particularly given the nature of the data, but in practice implementation in Bayesian framework gives clear benefits. There are difficulties evaluating the performance of the methods, but they work and save resources in managing large data sets. The use of neural networks allows more sophisticated pattern recognition to be performed.

Mesh:

Year:  2006        PMID: 16611210     DOI: 10.1111/j.1742-7843.2006.pto_232.x

Source DB:  PubMed          Journal:  Basic Clin Pharmacol Toxicol        ISSN: 1742-7835            Impact factor:   4.080


  15 in total

1.  A decade of data mining and still counting.

Authors:  Manfred Hauben; G Niklas Norén
Journal:  Drug Saf       Date:  2010-07-01       Impact factor: 5.606

2.  Potential use of data-mining algorithms for the detection of 'surprise' adverse drug reactions.

Authors:  Manfred Hauben; Sebastian Horn; Lester Reich
Journal:  Drug Saf       Date:  2007       Impact factor: 5.606

3.  What counts in data mining?

Authors:  Manfred Hauben; Vaishali K Patadia; David Goldsmith
Journal:  Drug Saf       Date:  2006       Impact factor: 5.606

4.  Illusions of objectivity and a recommendation for reporting data mining results.

Authors:  Manfred Hauben; Lester Reich; Charles M Gerrits; Muhammad Younus
Journal:  Eur J Clin Pharmacol       Date:  2007-03-16       Impact factor: 2.953

5.  'Extreme duplication' in the US FDA Adverse Events Reporting System database.

Authors:  Manfred Hauben; Lester Reich; James DeMicco; Katherine Kim
Journal:  Drug Saf       Date:  2007       Impact factor: 5.606

6.  Prospective data mining of six products in the US FDA Adverse Event Reporting System: disposition of events identified and impact on product safety profiles.

Authors:  Steven Bailey; Ajay Singh; Robert Azadian; Peter Huber; Michael Blum
Journal:  Drug Saf       Date:  2010-02-01       Impact factor: 5.606

7.  Controlled trials and risk of harm.

Authors:  I Ralph Edwards
Journal:  Drug Saf       Date:  2008       Impact factor: 5.606

Review 8.  Beyond debacle and debate: developing solutions in drug safety.

Authors:  Amrit Ray
Journal:  Nat Rev Drug Discov       Date:  2009-09-18       Impact factor: 84.694

9.  Adverse Events Associated With Botox as Reported in a Food and Drug Administration Database.

Authors:  Salma Ahsanuddin; Savannah Roy; Wissam Nasser; Roman Povolotskiy; Boris Paskhover
Journal:  Aesthetic Plast Surg       Date:  2020-10-30       Impact factor: 2.326

10.  Adverse Drug Reaction Risk Measures: A Comparison of Estimates from Drug Surveillance and Randomised Trials.

Authors:  Raphaelle Beau-Lejdstrom; Sarah Crook; Alessandra Spanu; Tsung Yu; Milo A Puhan
Journal:  Pharmaceut Med       Date:  2019-08
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.